Intrathecal therapy with trastuzumab may be beneficial in cases of refractory schizophrenia
Authors:
Open Access
- 1 April 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 62 (4) , 542-545
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Meta-analysis of the Efficacy of Second-Generation AntipsychoticsArchives of General Psychiatry, 2003
- Support for genetic variation in neuregulin 1 and susceptibility to schizophreniaMolecular Psychiatry, 2003
- Association of Neuregulin 1 with Schizophrenia Confirmed in a Scottish PopulationThe American Journal of Human Genetics, 2003
- Neuregulin 1 and Susceptibility to SchizophreniaThe American Journal of Human Genetics, 2002
- Use of Intrathecal Trastuzumab in a Patient with Carcinomatous MeningitisClinical Breast Cancer, 2001
- Neuregulin and ErbB receptor signaling pathways in the nervous systemCurrent Opinion in Neurobiology, 2001
- The neuropathology of schizophreniaBrain, 1999
- Neuregulins Promote Survival and Growth of Cardiac MyocytesJournal of Biological Chemistry, 1998
- Requirement for neuregulin receptor erbB2 in neural and cardiac developmentNature, 1995
- Multiple essential functions of neuregulin in developmentNature, 1995